Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICH Generic Drug Harmonization May Be Another Cost-Lowering Opportunity

Executive Summary

The international group will work on harmonizing scientific and technical standards for generic drugs, which could reduce duplication and development costs.
Advertisement

Related Content

Keeping Track: FDA Approves First Generic Advair, But Alkermes And Sunovion Land CRLs
Drug Safety Announcement Blitz Highlights Gottlieb's PR Savvy As Shutdown Drags On
Is Bloom Gone From Rosy ANDA Approvals Figures?
Why Data Integrity Concerns Led Fresenius To Back Away From Akorn Deal
FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124718

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel